Cargando…

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

Patients with schizophrenia have exceedingly high rates of metabolic comorbidity including type 2 diabetes and lose 15–20 years of life due to cardiovascular diseases, with early accrual of cardiometabolic disease. In this study, thirty overweight or obese (Body Mass Index (BMI) > 25) participant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Sri Mahavir, Panda, Roshni, Costa-Dookhan, Kenya A., MacKenzie, Nicole E., Treen, Quinn Casuccio, Caravaggio, Fernando, Hashim, Eyesha, Leung, General, Kirpalani, Anish, Matheson, Kelly, Chintoh, Araba F., Kramer, Caroline K., Voineskos, Aristotle N., Graff-Guerrero, Ariel, Remington, Gary J., Hahn, Margaret K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046796/ https://www.ncbi.nlm.nih.gov/pubmed/33854039 http://dx.doi.org/10.1038/s41398-021-01338-2

Ejemplares similares

M84. METFORMIN FOR EARLY CO-MORBID PREDIABETES OR DIABETES IN SCHIZOPHRENIA SPECTRUM DISORDERS: A DOUBLE BLIND RANDOMIZED PILOT STUDY
por: Mahavir Agarwal, Sri, et al.
Publicado: (2020)

S89. INVESTIGATING METABOLIC DYSFUNCTION AND METABOLOMIC PROFILE CHANGES IN ANTIPSYCHOTIC NAIVE PATIENTS
por: Costa-Dookhan, Kenya, et al.
Publicado: (2020)

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia
por: MacKenzie, Nicole E., et al.
Publicado: (2018)

Metabolomic signatures associated with weight gain and psychosis spectrum diagnoses: A pilot study
por: Lee, Jiwon, et al.
Publicado: (2023)

T231. QUALITY OF LIFE IN ANTIPSYCHOTIC-NAïVE YOUTH: EXPLORING THE INTERPLAY WITH METABOLIC SIDE-EFFECTS
por: Chintoh, Araba, et al.
Publicado: (2020)

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health
por: Stogios, Nicolette, et al.
Publicado: (2021)

Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis
por: Wu, Sally, et al.
Publicado: (2023)

Semaglutide for the treatment of antipsychotic-associated weight gain in patients not responding to metformin – a case series
por: Prasad, Femin, et al.
Publicado: (2023)

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls
por: Stogios, Nicolette, et al.
Publicado: (2022)

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis
por: Kanagasundaram, Pruntha, et al.
Publicado: (2021)

Associations between plasma clozapine/N-desmethylclozapine ratio, insulin resistance and cognitive performance in patients with co-morbid obesity and ultra-treatment resistant schizophrenia
por: Costa-Dookhan, Kenya A., et al.
Publicado: (2021)

Magnetic Resonance Elastography-derived Stiffness Predicts Renal Function Loss and Is Associated With Microvascular Inflammation in Kidney Transplant Recipients
por: Shatil, Anwar S., et al.
Publicado: (2022)

The role of thrombectomy and diffusion-weighted imaging with MRI in post-transplant renal vein thrombosis: a case report
por: Misra, Paraish, et al.
Publicado: (2017)

The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment
por: Raben, Alex T., et al.
Publicado: (2018)

Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-Management and Provider Engagement: Protocol for a Feasibility Trial
por: Kidd, Sean, et al.
Publicado: (2021)

Diffusion Tensor Imaging Findings in Post-Concussion Syndrome Patients after Mild Traumatic Brain Injury: A Systematic Review
por: Khong, Edrea, et al.
Publicado: (2016)

F219. NOVEL OBJECTIVE ASSESSMENT OF ACTIVITY ENGAGEMENT IN SCHIZOPHRENIA USING WIRELESS MOTION CAPTURE
por: Siddiqui, Ishraq, et al.
Publicado: (2018)

Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men
por: Caravaggio, Fernando, et al.
Publicado: (2018)

O1.5. CLUSTERING-BASED BEHAVIOURAL PHENOTYPES OF INTRINSIC MOTIVATION IN SCHIZOPHRENIA DETERMINED USING OBJECTIVELY QUANTIFIED REAL-WORLD PERFORMANCE
por: Siddiqui, Ishraq, et al.
Publicado: (2020)

Patterns of myeloarchitecture in lower limb amputees: an MRI study
por: Hashim, Eyesha, et al.
Publicado: (2015)

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2
por: Zai, Clement, et al.
Publicado: (2018)

A review of structural neuroimaging in schizophrenia: from connectivity to connectomics
por: Wheeler, Anne L., et al.
Publicado: (2014)

Behavioural phenotypes of intrinsic motivation in schizophrenia determined by cluster analysis of objectively quantified real-world performance
por: Siddiqui, Ishraq, et al.
Publicado: (2022)

S119. A DIMENSIONAL APPROACH TO UNDERSTANDING COST-BENEFIT DECISION-MAKING IN SCHIZOPHRENIA AND DEPRESSION
por: Saperia, Sarah, et al.
Publicado: (2020)

T224. TESTING THE EFFECTIVENESS OF A BRIEF, PEER SUPPORT INTERVENTION TO FACILITATE TRANSITION FROM PSYCHIATRIC HOSPITALIZATION FOR A SCHIZOPHRENIA SPECTRUM POPULATION
por: Kidd, Sean, et al.
Publicado: (2020)

A profile of brain reserve in adults at genetic risk of Alzheimer's disease
por: Coughlan, Gillian, et al.
Publicado: (2021)

Developing an evaluation framework for assessing the impact of recovery colleges: protocol for a participatory stakeholder engagement process and cocreated scoping review
por: Lin, Elizabeth, et al.
Publicado: (2022)

Characterization and prediction of individual functional outcome trajectories in schizophrenia spectrum disorders (PREDICTS study): Study protocol
por: Agarwal, Sri Mahavir, et al.
Publicado: (2023)

Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: App4Independence (A4i)
por: Kidd, Sean A., et al.
Publicado: (2019)

Metformin for the treatment of antipsychotic-induced metabolic disturbances in people with intellectual and developmental disabilities
por: Stogios, Nicolette, et al.
Publicado: (2023)

M49. BEHAVIOURAL SOCIAL COGNITION IN SCHIZOPHRENIA SPECTRUM DISORDERS IN COMPARISON TO AUTISM SPECTRUM DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Oliver, Lindsay, et al.
Publicado: (2020)

Unravelling the relationship between amyloid accumulation and brain network function in normal aging and very mild cognitive decline: a longitudinal analysis
por: Moffat, Gemma, et al.
Publicado: (2022)

An Examination of the Multi-Faceted Motivation System in Healthy Young Adults
por: Da Silva, Susana, et al.
Publicado: (2018)

Reduced Insulin Sensitivity Is Related to Less Endogenous Dopamine at D(2/3) Receptors in the Ventral Striatum of Healthy Nonobese Humans
por: Caravaggio, Fernando, et al.
Publicado: (2015)

The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders
por: Kozloff, Nicole, et al.
Publicado: (2020)

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review
por: Singh, Raghunath, et al.
Publicado: (2022)

Metabolic Syndrome in Schizophrenia: Theoretical, Clinical and Translational Perspectives
por: Agarwal, Sri Mahavir, et al.
Publicado: (2013)

F178. NEUROANATOMICAL PROFILES OF TREATMENT-RESISTANCE IN PATIENTS WITH SCHIZOPHRENIA
por: Plitman, Eric, et al.
Publicado: (2018)

S16. GLUTAMATERGIC NEUROMETABOLITE LEVELS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA: A CROSS-SECTIONAL 3T PROTON MRS STUDY
por: Iwata, Yusuke, et al.
Publicado: (2018)

Modeling and prediction of clinical symptom trajectories in Alzheimer’s disease using longitudinal data
por: Bhagwat, Nikhil, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1r32lssuo2trad4ottm3q1e71c